LaSara Medical Group review

What it is

LaSara Medical Group is a national telehealth practice with in-person availability in Southern California, running a multi-modality menu rather than a single-drug platform: compounded semaglutide and tirzepatide for weight, a "reverse aging" line with NAD⁺ injections and sermorelin, B12 injections, injectable testosterone cypionate, and enclomiphene as an alternative testosterone route. Intake begins with a free consultation and a medical form, and prescribing follows physician approval. Subscription orders are described as including delivery, physician monitoring and proactive check-ins.

How it works

Hybrid, which is rare here: national telehealth with the option of being seen in person in Southern California, under a named medical director and supervising physician. Product pages are structured as a storefront — you can see the subscription price and the one-time price side by side before starting anything — and the testosterone line is gated behind real requirements rather than a questionnaire alone: total testosterone, free testosterone, a complete blood count and a total PSA no more than six months old, or new testing through LaSara. That gate is the correct standard for testosterone and a good sign about how the practice runs. The gaps are on paperwork. No legal entity or state of incorporation is disclosed, the compounding pharmacy is not named — the site claims only that it sources semaglutide exclusively from LegitScript-certified compounding pharmacies, which is a claim about its suppliers rather than a certification of itself — and no per-state availability list is published despite the national telehealth positioning. Its own product pages also carry benefit copy without a compounded-medication disclaimer alongside, which is a disclosure the practice should tighten.

Pricing transparency

Published and comparable, which is the headline. Sermorelin is $199/mo on subscription and $249 as a one-time purchase. The NAD⁺ injection is $225/mo on subscription and $250 one-time, and — unusually — the page states the formulation as 200 mg/ml supplied as a 10 ml vial, so you can work out what you are buying rather than comparing two unlabelled monthly fees. Testosterone is $169/mo, described as including the medication, treatment supplies, follow-up medical consults, routine lab work, free shipping and automatic refills, with new lab testing available for $69 if your existing panel is over six months old. Bundled routine labs are the detail that changes the real cost of testosterone therapy, because monitoring is not optional. On the GLP-1 side, compounded semaglutide is $289/mo on subscription and tirzepatide $399 for one month, with multi-month bundles down to $233 and $325 per month — but those bundles require paying the full term up front, and none of those figures is a peptide or testosterone price.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. LaSara does not name the pharmacy that prepares its compounded products, and compounded sterile preparations are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence the menu splits three ways. Sermorelin is a GHRH analogue acting on your own pituitary — a real mechanism, thin long-term human outcome data. Injected NAD⁺ has no controlled human outcome trials whatever the concentration on the vial; the forms with human data are the oral precursors NR and NMN, which raise blood NAD⁺, a biomarker rather than an outcome. Testosterone replacement is the outlier with a genuine randomised evidence base, including a large cardiovascular safety trial, but it also carries real monitoring obligations — haematocrit, PSA and testosterone levels — and suppresses natural production and fertility, which is precisely why LaSara's lab gate exists. Enclomiphene is the opposite trade: it raises endogenous testosterone by blocking oestrogen feedback at the pituitary and preserves fertility, but it is not FDA-approved for that use and is prescribed compounded. Individual results vary.

Pros and watch-outs

The evidence behind what LaSara Medical Group prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• TRT: what testosterone therapy is actually proven to do

  An FDA-approved therapy for diagnosed hypogonadism — with real but moderate benefits (sexual function, mood; not vitality), cardiovascular non-inferiority in TRAVERSE, and a real fertility trade-off.

• Enclomiphene: the evidence for restoring testosterone without replacing it

  Randomized trials, including two Phase III RCTs, show enclomiphene restores a man's own testosterone while preserving fertility — but it was never FDA-approved.

How LaSara Medical Group compares

A few alternatives worth a look, depending on what you’re optimizing for.

• KOKongo

  NAD⁺ injections at a published flat rate across all 50 states

  See Kongo →
• LRLevelUp Rx

  NAD⁺ injections from a platform that names the pharmacies dispensing them

  See LevelUp Rx →
• LHLevers Health

  NAD⁺ injections priced openly on a storefront rather than quoted after intake

  See Levers Health →